The legal team of the civil rights organisation AfriForum sent a formal PAIA application to the Ministerial Advisory Committee on COVID-19 (MAC) and the South African Health Products Regulatory Authority (SAHPRA) to obtain from these institutions the documents and information that relate to the review of ivermectin for the prevention and treatment of COVID-19.
AfriForum and the I Can Make a Difference group of doctors earlier requested the MAC, SAHPRA, the National Essential Medicine List Committee (NEMLC) and the Infectious Diseases Society of South Africa (IDSSA) to provide their review documents on ivermectin. This step was taken after prof. Helen Rees, chairperson of SAHPRA, indicated that these four institutions independently reviewed the available data on ivermectin for the prevention and treatment of COVID-19.
The NEMLC referred AfriForum and I Can Make a Difference to the webpage of the Department of Health, where only an outdated ivermectin review document form January is available. The IDSSA indicated that the institution does not have such a document.
“More information about the positive impact of ivermectin on the prevention and treatment of COVID-19 has come to light in the last months. One example of this is a meta-analysis that was published in the American Journal of Therapeutics yesterday. The analysis found that the use of ivermectin can reduce the risk of death by 62% and risk of infection by 86%. The implementation of prevention and early treatment of COVID-19 with a combination of repurposed medicines can reduce pressure on hospitals and save lives. Everything points to the fact that the authorities’ current recommendation on ivermectin is based on outdated information. If the review of ivermectin was conducted independently by the four institutions, surely the documents relating to that must be available and can be provided on request? The question must be asked whether the public is deliberately misled or if those in leadership positions do not know what is happening,” says Barend Uys, Head of Research at AfriForum.
AfriForum encourages medical doctors and the public to take responsibility and do research themselves on the prevention and early treatment of COVID-19 with safe, well-known and affordable repurposed medicines. Good sources of information is the FLCCC in the USA, BIRD in the United Kingdom and the webpage https://c19early.com/.